📰 ET Stocks 🟢 BULLISH 🕒 19 Oct 2026, 02:02 PM IST

UltraTech Cement Q2 Results: Net profit jumps 21% YoY to Rs 1,494 crore; revenue up 19%

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: UltraTech Cement Q2 Results: Net profit jumps 21% YoY to Rs 1,494 crore; revenue up 19%

📊

Market & Financial Impact: UltraTech Cement Q2 Results: The company’s revenue from operations increased 19% year-on-year to Rs 23,295 crore in Q2 FY27, from Rs 19,607 crore in the year-ago period

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Business of Odd Things: Inside an industry that farms fish that nobody is meant to eat

War's second-order effects are becoming visible in critical sectors

US mid-term elections – Part 2: What does it mean for Trump to lose control of Congress?

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

UltraTech Cement Q2 Results: Net profit jumps 21% YoY to Rs 1,494 crore; revenue up 19%

🔥 More Live Market Stories

Taking Stock: Market snaps 2-day gains; Nifty below 22,900, Sensex tanks 876 pts

The S&P 500 is masking a hidden market pullback. Why Morgan Stanley says an index retreat would signal a buying opportunity.

[TATVA] Outcome of Board Meeting - Tatva Chintan Pharma Chem Limited

[EMKAY] General Updates - Emkay Global Financial Services Limited

Earnings-led sell-off drags multibagger CCL Products to 7-month low. Can it fall further? Axis Direct rationale

Fed sees AI boom adding to inflation headache, but others may pay for the medicine